Publications by authors named "N Ganesan"
Purpose: We conducted a phase I/II study evaluating nivolumab plus doxorubicin, vinblastine, dacarbazine (N-AVD) as frontline therapy for treatment-naïve older adults (OA) with classical Hodgkin lymphoma (cHL; ClinicalTrials.gov identifier: NCT03033914).
Methods: Patients age ≥60 years with newly diagnosed, any stage, cHL were treated with six cycles of AVD at standard doses plus nivolumab 240 mg intravenously once every 2 weeks (on days 1 and 15) of each cycle.
In this study, garlic-oil-combined cellulose fibers were prepared by using Borassus flabellifer (Asian Palmyra palm) to enhance the post-harvest shelf life of tomatoes. The physicochemical properties of the prepared cellulose fibers were characterized by using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and field emission scanning electron microscopy (FE-SEM). The B.
View Article and Find Full Text PDFArticle Synopsis
- Nattokinase (NK), an enzyme in fermented Japanese food, was studied for its potential neuroprotective effects against brain damage caused by reduced blood flow.
- The study involved behavioral assessments and various biological measurements after administering different doses of NK and comparing its effects to a standard treatment, streptokinase (STK).
- Results showed that NK significantly improved cerebral blood flow and neurological functions, suggesting its potential as a preventive treatment for ischemic brain damage.